about
Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress.Relation of plasma tissue kallikrein levels to presence and severity of coronary artery disease in a Chinese population.Comparative proteomics of cerebrospinal fluid reveals a predictive model for differential diagnosis of pneumococcal, meningococcal, and enteroviral meningitis, and novel putative therapeutic targets.Effects of kinin B(1) and B(2) receptor antagonists on overactive urinary bladder syndrome induced by spinal cord injury in rats.Kidney tubules: intertubular, vascular, and glomerular cross-talk.Targeting the 'Janus face' of the B2-bradykinin receptor.Kidney-lung connections in acute and chronic diseases: current perspectives.Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity.Neuroprotective effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mice.Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykininImplication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.Kallikrein–Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis.Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
P2860
Q27348019-1D840FCD-2E32-4F37-B3DF-900FF90E630FQ34368742-8A95EC56-C774-49E4-90DE-EB8B3DDB2097Q35120196-C01C14BF-9BB7-4BC2-92F4-FC6D164F376AQ35651817-908DB32F-A3C4-495F-B723-586EEA2B3C2BQ36476754-D4054433-FEA0-49D6-AC4A-DDD0AAB1E78FQ36837774-2E453095-3963-495A-A542-0573AAF55C0DQ38129928-C2835A26-32B8-477B-A341-9D5313F36E45Q38759694-806DFCAC-4F84-4E6F-B35B-50501B42D216Q38853318-03F25A4B-B1CE-4D2D-848C-5B91D02E6B22Q41529359-EB12EC34-EFBD-4B45-AD33-6A2FD6DF32BCQ42276007-65D948F0-492D-41F0-B650-70EA722CD96BQ47720411-992FF212-B879-4B4C-B724-6D4E4B8EB6C1Q49852055-638B1795-9455-4F65-8EC4-006F0E7E3EB1Q49884872-AB59E7B3-9EA7-4DF2-9EBA-EDFD3B8FA755Q50485658-6CC4CD38-F393-489E-BED1-50F9588F3392Q58797121-BA04C390-9B4E-44C4-BD79-878979D364D3
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The kallikrein-kinin system and oxidative stress
@ast
The kallikrein-kinin system and oxidative stress
@en
The kallikrein-kinin system and oxidative stress
@nl
type
label
The kallikrein-kinin system and oxidative stress
@ast
The kallikrein-kinin system and oxidative stress
@en
The kallikrein-kinin system and oxidative stress
@nl
prefLabel
The kallikrein-kinin system and oxidative stress
@ast
The kallikrein-kinin system and oxidative stress
@en
The kallikrein-kinin system and oxidative stress
@nl
P2860
P1476
The kallikrein-kinin system and oxidative stress
@en
P2093
Masao Kakoki
Yukako Kayashima
P2860
P356
10.1097/MNH.0B013E32834D54B1
P407
P577
2012-01-01T00:00:00Z